We are proud to support the National Organization for Rare Disorders #LivingRareForum being held in Los Angeles, CA and virtually! Learn more about this year’s dynamic program here: r.chiesi.com/8fgcuc0f NORD

As a proud supporter of #EUNOS2024, we look forward to joining clinical experts in exploring innovative advancements in the field of neuro-ophthalmology, including updates related to research in #LHON. To learn more about the meeting, visit: r.chiesi.com/j70bc7lr EUNOSsociety

In The Parliament's Policy Report on Health & Wellbeing, Enrico Piccinini considers the collective burden of rare diseases and the need for an ecosystem that increases investment in research and early diagnosis, including #NewbornScreening and timely treatment: r.chiesi.com/5fnoppck

Our team is honored to be recognized as an Industry Innovator for our work to advance a therapeutic option for people with #AlphaMannosidosis in the U.S., and we look forward to joining our fellow honorees at the #RareImpactAwards on June 8: r.chiesi.com/4p08ekc7 NORD

We are proud to partner with CENTOGENE to support critical efforts to help accelerate the diagnosis of rare and neurodegenerative diseases. Learn more about key updates related to the CENTOGENE Biodatabank: r.chiesi.com/8212gg0q #RareDiseases

During the 2nd World Congress on Rare Skin Diseases, we are hosting a symposium to share new insights on the management of epidermolysis bullosa and highlight daily challenges associated with EB. Learn more about the congress here: r.chiesi.com/p45v9qem

Applications for the Chiesi Golden Ticket Competition are due June 30! Apply now for a chance to receive one year of BioLabs membership, plus access to a dedicated laboratory bench at one of BioLabs’ U.S. site locations: r.chiesi.com/jmc87l7n #RareDiseases

In this article, Patient Worthy shares the impactful story of how Brian and Tia Jones’ journey with Fabry disease led to the launch of Testing for Tots – a program affiliated with FSIG to support early diagnosis initiatives through #NewbornScreening: r.chiesi.com/8k5xbqpp

Applications for the Chiesi FAST Discovery Award are open until July 1! This special recognition will honor the aspiring life science companies and entrepreneurs who are driving scientific innovation in #RareDiseases. Apply here: r.chiesi.com/yx877k66 California Life Sciences (CLS)

We are excited to share that we have partnered with CheckRare to launch a new series of podcast episodes focused on #Fabry disease. Check out the first episode featuring a discussion with biochemical geneticist Dr. William Burns about the impact of Fabry: r.chiesi.com/86mvtpgg

In this white paper, The Rare Disease Company Coalition highlights the value of the rare pediatric disease priority review voucher (PRV) program and discusses the need to take action to ensure its continued impact on future advancements in #RareDisease treatments: r.chiesi.com/4idqf1be

Our team was honored to attend the #RareImpactAwards! During the ceremony, we celebrated the achievements of changemakers throughout the #RareDisease community and were pleased to accept an Industry Innovator award for our work to advance a therapy for #AlphaMannosidosis.

During #ECRD2024, we joined EURORDIS-Rare Diseases Europe in supporting an open letter calling on the next European leaders to prioritize policies and initiatives that address the unmet needs of the 30 million people living with #RareDiseases in the EU. Read the full letter: r.chiesi.com/jzq7n2cb

In the next installment of a new podcast series focused on Fabry disease, CheckRare connects with Dr. Nicola Longo, an expert in pediatrics and medical genetics, for an in-depth discussion about the symptoms associated with #Fabry. Listen here: r.chiesi.com/gcskw2fh

As a member of the CPLD Consortium, we are proud to collaborate with the Critical Path Institute (C-Path) to drive innovation centered on making a positive impact for people living with rare lysosomal diseases and their families. Learn more: r.chiesi.com/7dq9869h Chiesi Group

In this CheckRare podcast episode, patient advocate Maya shares insights from her journey with #Fabry and highlights the important role that mental health support plays when managing daily challenges associated with the disease: r.chiesi.com/80451g06

In this white paper, NORD provides a comprehensive overview of the rare pediatric disease priority review voucher program and its impact on rare disease drug development: r.chiesi.com/5lr14b8k Learn more about the PRV program from NORD here: r.chiesi.com/0n10tq61

During our symposium at #SSIEM2024, a panel of experts in lysosomal storage disorders will review the pathogenesis, clinical presentation, and management of real #AlphaMannosidosis clinical cases. Learn more about @ssiem2024_porto: r.chiesi.com/73b8n53h

We look forward to hearing from specialists in lysosomal storage disorders about the latest clinical data in #Fabry disease and the importance of integrating the patient voice with clinical perspectives during our #SSIEM2024 symposium. r.chiesi.com/3wxqgxdv @ssiem2024_porto

In partnership with FSIG, Testing for Tots is an organization dedicated to enabling the early diagnosis of #Fabry disease. Learn more about the important efforts being led by founders Brian and Tia Jones in this Authority Magazine article: r.chiesi.com/336vyesp